Corrigendum | Open Access
Aikaterini Thanou, Tauseef Ali, Omar Haq, Sindhu Kaitha, Jordan Morton, Stavros Stavrakis, Mary Beth Humphrey, "Corrigendum to “Utilization of Preventive Measures for Glucocorticoid-Induced Osteoporosis among Veterans with Inflammatory Bowel Disease”", International Scholarly Research Notices, vol. 2017, Article ID 2365840, 1 page, 2017. https://doi.org/10.1155/2017/2365840
Corrigendum to “Utilization of Preventive Measures for Glucocorticoid-Induced Osteoporosis among Veterans with Inflammatory Bowel Disease”
In the article titled “Utilization of Preventive Measures for Glucocorticoid-Induced Osteoporosis among Veterans with Inflammatory Bowel Disease” , there was an error regarding the FRAX® tool, which should be clarified as follows.
The article notes, “the WHO fracture risk predictor model (FRAX) designed to incorporate such factors in a comprehensive assessment tool has shown promising preliminary results in patients with IBD”. However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations . The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but treatment guidelines must undergo a formal process before they can be endorsed by the WHO.
- A. Thanou, T. Ali, O. Haq et al., “Utilization of preventive measures for glucocorticoid-induced osteoporosis among veterans with inflammatory bowel disease,” ISRN Gastroenterology, vol. 2013, Article ID 862312, 5 pages, 2013.
- Nathan Ford, Susan L. Norris, and Suzanne R. Hill, “Clarifying WHO’s position on the FRAX® tool for fracture prediction,” Bulletin of the World Health Organization, vol. 94, 862 pages, 2016.
Copyright © 2017 Aikaterini Thanou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.